近日,國家藥監(jiān)局印發(fā)《醫(yī)療器械分類規(guī)則(修訂草案征求意見稿)》,公開征求意見時(shí)間是2025年4月7日—5月7日。醫(yī)療器械分類規(guī)則(修訂草案征求意見稿)第一條?為規(guī)范醫(yī)療器械分類,根據(jù)《醫(yī)療器械監(jiān)督管理?xiàng)l例》,制定本規(guī)則。第二條?本規(guī)則用于指導(dǎo)分類界定指導(dǎo)原則和醫(yī)療器械分...
來源:山東省住房和城鄉(xiāng)建設(shè)廳...
近日,為全面貫徹落實(shí)黨的二十大和二十屆二中、三中全會精神,按照中央經(jīng)濟(jì)工作會議和2025年政府工作報(bào)告部署,加快構(gòu)建促進(jìn)數(shù)字經(jīng)濟(jì)發(fā)展體制機(jī)制,國家發(fā)展改革委、國家數(shù)據(jù)局印發(fā)《2025年數(shù)字經(jīng)濟(jì)發(fā)展工作要點(diǎn)》。工作要點(diǎn)對2025年推進(jìn)數(shù)字經(jīng)濟(jì)高質(zhì)量發(fā)展重點(diǎn)工作作出部署,提...
近期,創(chuàng)新藥明顯成為市場的主力,創(chuàng)新藥指數(shù)多次狂飆。如4月1日,歐康醫(yī)藥盤中“30cm”漲停,隴神戎發(fā)、多瑞醫(yī)藥、誠達(dá)藥業(yè)等“20cm”漲停;誠達(dá)藥業(yè)、艾迪藥業(yè)、一品紅、榮昌生物、鍵凱科技、成都先導(dǎo)等個(gè)股也漲?;驖q超10%? 對此,分析人士認(rèn)為,創(chuàng)新藥板塊的爆發(fā)并非偶...
各會員企業(yè):為進(jìn)一步加強(qiáng)制藥裝備企業(yè)與制藥工業(yè)企業(yè)之間的技術(shù)交流與合作,促進(jìn)雙方共同發(fā)展;幫助企業(yè)了解先進(jìn)制藥裝備技術(shù),推動制藥裝備技術(shù)研發(fā)和創(chuàng)新,促進(jìn)醫(yī)藥行業(yè)高質(zhì)量發(fā)展。商會秘書處經(jīng)研究決定,在一線專家委員會內(nèi)組建制藥裝備技術(shù)專家組。根據(jù)全國工商聯(lián)醫(yī)藥業(yè)商會《一線專家...
今年政府工作報(bào)告提出,積極穩(wěn)妥推進(jìn)碳達(dá)峰碳中和。扎實(shí)開展國家碳達(dá)峰第二批試點(diǎn),建立一批零碳園區(qū)、零碳工廠。作為石油和化工行業(yè)綠色低碳發(fā)展的主陣地,石油和化工園區(qū)在建設(shè)零碳園區(qū)過程中面臨哪些機(jī)遇?生物能源在此過程中又將擔(dān)當(dāng)什么角色? 近期,中國化工報(bào)記者就我國石化零碳園...
全國范圍內(nèi)新一輪聚焦醫(yī)院以及藥店的醫(yī)?;鸨O(jiān)管即將開始。01國家醫(yī)保局等九部門開會部署醫(yī)?;饘m?xiàng)整治工作4月3日,國家醫(yī)保局會同最高人民法院、最高人民檢察院、公安部、財(cái)政部、國家衛(wèi)生健康委、市場監(jiān)管總局、國家中醫(yī)藥局、國家藥監(jiān)局等九部門,聯(lián)合召開全國醫(yī)?;鸸芾硗怀鰡?..
2025-04-17
2025-04-17
2025-04-17
2025-04-17
2025-04-17
2025-04-17
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-09
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-04-01
2025-03-26
2025-03-26
2025-03-26
2025-03-26
2025-03-26
2025-03-26
2025-03-26
2025-03-24
2025-03-20
2025-03-19
2025-03-19
2025-03-19
2025-03-19
2025-03-19
2025-03-19
2025-03-19
2025-03-19
2025-03-18
2025-03-18
2025-03-18
2025-03-18
2025-03-14
2025-03-14
2025-03-14
2025-03-14
2025-03-11
2025-03-11
2025-03-10
2025-03-10
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-03-04
2025-02-25
2025-02-25
2025-02-21
2025-02-21
2025-02-18
2025-02-16
2025-02-16
2025-02-13
2025-02-13
2025-02-11
2025-02-11
2025-02-11
2025-02-07
2025-02-07
2025-02-07
2025-02-07
2025-02-07
2025-02-07
2025-02-06
2025-02-06
2025-02-04
2025-01-26
2025-01-23
2025-01-23
2025-01-23
2025-01-23
2025-01-23
2025-01-20
2025-01-20
2025-01-20
2025-01-20
2025-01-17
2025-01-17
2025-01-15
2025-01-15
2025-01-15
2025-01-14
2024-09-23
2024-08-12
2024-08-12
2024-08-12
2024-08-08
2024-07-12
2024-07-12
2024-06-19
2024-06-19
2024-06-19
2024-06-18
2024-06-14
2024-06-14
2024-06-14
2024-03-25
2024-03-25
2024-03-25
2024-03-18
2024-03-18
2024-03-12
2024-03-12
2024-03-04
2024-03-04
2024-03-04
2024-03-04
2024-03-04
2024-02-27
2024-02-27
2024-02-27
2024-02-27
2024-01-23
2024-01-23
2024-01-23
2024-01-17
2024-01-17
2024-01-17
2024-01-17
2024-01-10
2024-01-10
2024-01-10
2024-01-10
2023-10-18
2023-10-18
2023-09-22
2023-09-22
2023-09-22
2023-09-22
2023-09-22
2023-08-23
2023-08-23
2023-08-17
2023-08-17
2023-08-17
2023-08-09
2023-08-09
2023-08-09
2023-08-09
2023-08-01
2023-08-01
2023-07-13
2023-07-13
2023-07-13
2023-07-05
2023-07-05
2023-07-05
2023-06-21
2023-06-21
2023-06-21
2023-06-14
2023-06-14
2023-06-14
2023-06-14
2023-06-14
2023-06-08
2023-06-08
2023-06-08
2023-06-08
2023-06-08
2023-06-08
2023-05-31
2023-05-31
2023-05-31
2023-05-24
2023-05-24
2023-05-24
2023-05-24
2023-05-24
2023-03-09
2023-03-09
2023-03-09
2022-11-02
2022-10-12
2022-09-15
2022-09-15
2022-09-02
2022-08-25
2022-08-25
2022-08-10
2022-08-10
2022-07-27
2022-07-26
2022-07-20
2022-07-14
2022-07-14
2022-07-06
2022-07-06
2022-05-17
2022-05-17
2022-05-17